Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,637,648
  • Shares Outstanding, K 606,218
  • Annual Sales, $ 5,382 M
  • Annual Income, $ 1,522 M
  • 60-Month Beta 1.01
  • Price/Sales 9.68
  • Price/Cash Flow 31.22
  • Price/Book 8.56
Trade EW with:

Options Overview Details

View History
  • Implied Volatility 23.39% ( +0.43%)
  • Historical Volatility 22.59%
  • IV Percentile 2%
  • IV Rank 11.33%
  • IV High 47.96% on 06/30/22
  • IV Low 20.25% on 02/08/23
  • Put/Call Vol Ratio 0.58
  • Today's Volume 282
  • Volume Avg (30-Day) 1,424
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 56,585
  • Open Int (30-Day) 58,427

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.65
  • Number of Estimates 12
  • High Estimate 0.66
  • Low Estimate 0.63
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +3.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.94 +3.14%
on 05/25/23
89.72 -6.95%
on 05/15/23
-5.26 (-5.93%)
since 05/05/23
3-Month
73.54 +13.52%
on 03/13/23
89.72 -6.95%
on 05/15/23
+4.56 (+5.78%)
since 03/07/23
52-Week
67.13 +24.36%
on 11/08/22
107.92 -22.65%
on 07/28/22
-13.77 (-14.16%)
since 06/07/22

Most Recent Stories

More News
DATA FROM BENCHMARK REGISTRY DEMONSTRATE IMPROVED TAVR EFFICIENCY WITH PRESERVED PATIENT SAFETY

/PRNewswire/ -- Edwards Lifesciences (NYSE: EW) announced today that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness...

EW : 83.48 (-2.00%)
Syneos Health (SYNH) Tops Q1 Earnings, Announces Merger Plan

Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be acquired by a private investment consortium.

SYNH : 41.75 (+0.53%)
JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
SmileDirectClub (SDC) Q1 Earnings Miss, Gross Margin Up

SmileDirectClub (SDC) Q1 revenues are affected by persistent macroeconomic headwinds.

JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
SDC : 0.4026 (-1.71%)
Exact Sciences (EXAS) Q1 Earnings Top, Sales View Raised

The upside in Exact Sciences' (EXAS) screening revenues is primarily coming from broad-based momentum in Cologuard adoption.

JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
EXAS : 87.76 (+2.98%)
Henry Schein (HSIC) Q1 Earnings Miss, Operating Margin Dips

Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.

HSIC : 75.26 (-0.15%)
JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
Omnicell's (OMCL) New Acquisitions Aid Growth, Cost Woes Stay

Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.

JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
OMCL : 75.94 (+1.99%)
Bruker's (BRKR) New Buyout to Advance Digital Transformation

Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.

JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
BRKR : 75.58 (+2.31%)
Here's Why You Should Retain Abbott (ABT) Stock For Now

Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.

ABT : 101.66 (-0.94%)
JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
Teleflex (TFX) Q1 Earnings Top Estimates, 2023 Sales View Up

Teleflex (TFX) registers growth across the majority of its businesses, including double-digit increases in interventional and surgical revenues in Q1.

JNJ : 158.52 (+0.21%)
ISRG : 307.24 (-2.69%)
EW : 83.48 (-2.00%)
TFX : 240.09 (+1.74%)
EDWARDS' AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA

/PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve...

EW : 83.48 (-2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 87.85
2nd Resistance Point 86.66
1st Resistance Point 85.07
Last Price 83.48
1st Support Level 82.29
2nd Support Level 81.10
3rd Support Level 79.51

See More

52-Week High 107.92
Fibonacci 61.8% 92.34
Fibonacci 50% 87.52
Last Price 83.48
Fibonacci 38.2% 82.71
52-Week Low 67.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar